Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans (Q44187600)

30 November 2017

Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans (English)

1 reference

30 November 2017

Gunvor Ahlborg

1

1 reference

PubMed ID

12391119

30 November 2017

Jonas Lindström

series ordinal

2

1 reference

PubMed ID

12391119

30 November 2017

language of work or name

English

0 references

publication date

6 September 2002

1 reference

Journal of Applied Physiology

30 November 2017

1 reference

30 November 2017

93

1 reference

30 November 2017

6

1 reference

30 November 2017

2112-2121

1 reference

Cyclooxygenase inhibition potentiates the renal vascular response to endothelin-1 in humans.

30 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Metabolic and vascular effects of circulating endothelin-1 during moderately heavy prolonged exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Cloning and expression of a cDNA encoding an endothelin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Nitric oxide and coronary endothelial dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

How to measure insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Molecular characterization of endothelin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Elevated plasma endothelin in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00477.2002

10.1152/JAPPLPHYSIOL.00477.2002

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12391119